Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Big Business This Week: Can Anyone Make Sense of Wall Street?
We try! Also: Google get clobbered, Musk sues advertisers, and an introduction to Walzonomics.
Top Dining Out Trends This Summer
OpenTable CEO joins Cheddar to discuss this summer's top restaurant trends, how best to make a reservation and what perks you can now get on the app. Watch!
Total Wireless Goes Big On Customer Satisfaction
Nancy Clark, President of Verizon Value, on Total Wireless’s rebranding and its commitment to top speeds, network quality, and value for prepaid customers.
The Heat Is On. Traeger Grills Sizzles In Q2
Traeger CEO Jeremy Andrus discusses the company’s latest earnings and how to properly sear a steak.
Class Is In Session: Master Your Finances With This Retired NFL Star
"Your Money Playbook" by Brandon Copeland offers practical advice on earning, managing, and building wealth, drawing from his NFL career and business education.
Microsoft Hits Back at Delta Over Claim Tech Outage Cost $500 Million
Microsoft is joining cybersecurity firm CrowdStrike in fighting back against criticism from Delta Air Lines.
What Happened? Markets Rebound After Chaos; Recession & Fed Cuts Loom
Chaos at the NYSE starts the week with crashing stocks and recession fears. Attention shifts to sectors, small caps, and AI spending.
Get Rich B*tch: How Frich Is Transforming Gen Z's Finances
Frich is a social finance app that tackles Gen Z’s financial obstacles and promotes open money discussions.
Fed's Delay Sparks Global Sell-Off
As markets plunge and economic fears rise, investors speculate the Fed might cut rates urgently.
